Rubynanomed focuses on the development of innovative nanomedicine solutions for drug delivery and diagnostics. They utilize advanced nanotechnology to create nanoparticle-based systems that improve the targeting and efficacy of therapeutic agents while minimizing side effects. Rubynanomed's platforms are designed to enhance the delivery of drugs to specific tissues or cells, providing more effective treatments for various diseases, including cancer and infectious diseases. Their technology aims to revolutionize the way medications are delivered and improve patient outcomes by making treatments more precise and efficient. For example, RUBYchipâ„¢, the first non-invasive and easy-to-use cancer progression monitoring device, enables oncologists to monitor the evolution of cancer in each patient in a minimally invasive, cost-efficient way.
